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Abstract
Background: Glaucoma is the leading cause of irreversible blindness worldwide. There tends to be a lower reporting
of glaucoma in Africa compared to other blinding conditions in global burden data. Research findings of glaucoma in
Nigeria will significantly increase our understanding of glaucoma in Nigeria, in people of the West African diaspora and
similar population groups. We determined the prevalence and types of glaucoma in Nigeria from the Nigeria National
Blindness and Visual Impairment cross-sectional Survey of adults aged ≥40 years.
Methods: Multistage stratified cluster random sampling with probability-proportional-to-size procedures were used to
select a nationally representative sample of 15,027 persons aged ≥40 years. Participants had logMAR visual acuity
measurement, FDT visual function testing, autorefraction, A-scan biometry and optic disc assessment. Participants
with visual acuity of worse than 6/12 or suspicious optic discs had detailed examination including Goldmann
applanation tonometry, gonioscopy and fundus photography. Disc images were graded by Moorfields Eye
Hospital Reading Centre. Glaucoma was defined using International Society of Geographical and Epidemiological
Ophthalmology criteria; and classified into primary open-angle or primary angle-closure or secondary glaucoma.
Diagnosis of glaucoma was based on ISGEO classification. The type of glaucoma was determined by gonioscopy.
Results: A total of 13,591 participants in 305 clusters were examined (response rate 90.4 %). Optic disc grading
was available for 25,289 (93 %) eyes of 13,081 (96 %) participants. There were 682 participants with glaucoma; a
prevalence of 5.02 % (95 % CI 4.60–5.47). Among those with definite primary glaucoma that had gonioscopy
(n = 243), open-angle glaucoma was more common (86 %) than angle-closure glaucoma (14 %). 8 % of glaucoma
was secondary with the commonest causes being couching (38 %), trauma (21 %) and uveitis (19 %). Only 5.6 %
(38/682) of participants with glaucoma knew they had the condition. One in every 5 persons with glaucoma
(136;20 %) was blind i.e., visual acuity worse than 3/60.
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Conclusion: Nigeria has a high prevalence of glaucoma which is largely open-angle glaucoma. A high proportion
of those affected are blind. Secondary glaucoma was mostly as a consequence of procedures for cataract. Public
health control strategies and high quality glaucoma care service will be required to reduce morbidity and
blindness from glaucoma.
Keywords: Prevalence, Glaucoma, Epidemiology, Nigeria, Open-angle glaucoma, Angle-closure glaucoma
Background
Glaucoma is the second leading cause of blindness world-
wide and the leading cause of irreversible blindness, ac-
counting for 8 % of all blindness, affecting an estimated
3.12 million blind people [1]. A review of relevant
population-based surveys of glaucoma, and of blindness
and visual impairment in sub-Saharan Africa indicate that
glaucoma affects about 4 % of adults aged 40 years and
above and accounts for 15 % of blindness [2–4]. Africa is
the region with the highest incidence and prevalence of
glaucoma, most of which is open-angle glaucoma (OAG)
[5, 6], and OAG is more prevalent in the black popula-
tions of Africa and Africa-derived populations [7]. Reports
also suggest that the most difficult problematic OAG that
there is in terms of severity of disease, difficulty in treating
it and as a cause of blindness comes from West Africa
[2, 3, 8]. Additionally, there tends to be a lower report-
ing of glaucoma in Africa compared to other blinding
conditions in global burden data because surveys in Af-
rica may have had limited diagnostic capacity for glau-
coma [9]. The Nigeria national blindness and visual
impairment survey (hereafter referred to as the Nigeria
Blindness Survey), in which over 13,500 people aged
40 years and above were examined, is a population-
based survey that substantially addresses glaucoma
prevalence and risk factors. The Nigeria Blindness Sur-
vey reported the prevalence of blindness to be 4.2 % (95 %
confidence interval 3.8–4.6 %) [10], 16.7 % being due to
glaucoma [11]. Glaucoma was the leading cause of irre-
versible blindness [11] and functional low vision [12].
A standard definition and classification system for
glaucoma in prevalence surveys proposed by the Inter-
national Society of Geographical and Epidemiological
Ophthalmology (ISGEO) [13] allows comparison of
glaucoma prevalence surveys, further highlighting the
variation between populations. Whereas angle-closure
glaucoma is more frequent among east Asian popula-
tions [6, 14], the black populations of USA [15] the
Caribbean [16, 17], and Africa [6, 18–22] have the
highest prevalence of open-angle glaucoma with up to
90 % of those affected being unaware that they have
the condition [18, 21, 22].
In this study, data from the Nigeria Blindness Survey
were analyzed using ISGEO criteria to determine the
prevalence and types of glaucoma, to provide data for
advocacy, policy and to plan services for glaucoma. How-
ever, the ISGEO classification system is not for clinical
diagnosis or for assessment for treatment of glaucoma.
The percentile values for the vertical cup:disc ratio
(VCDR), VCDR asymmetry and intraocular pressure
(IOP) to define glaucoma were derived from this study
population. Possible risk factors for glaucoma in the popu-
lation are presented in another paper.
Nigeria is the 7th most-populous country in the world
and had a total population of 128 million at the time of the
national survey (January 2005 to June 2007). Nigeria has 6
main administrative/geo-political zones (GPZ): north-east
(NE), south-east (SE), south-south (SS), north-west (NW),
south-west (SW) and north-central (NC). Two-thirds
(63 %) of the population live in rural areas. Nigeria has
more than 250 ethnic groups, who live in different
areas in the country each with their own language/dia-
lects, customs and practices. The largest ethnic groups
are the Hausa and Fulani in the north, Ibo in the south-east
and Yoruba in the south-west. Despite recent economic de-
velopment, adult literacy levels remain low (51 %), and
54 % of the population live below the poverty line on less
than a dollar a day [23].
There are insufficient population-based glaucoma stud-
ies in Africa to represent the entire continent in global
glaucoma prevalence estimates [6]. From the few high-
quality surveys, it is difficult to extrapolate the findings to
wider populations as they were conducted in limited and
defined geographical areas of large countries [3]. This is
the largest truly population-based study of glaucoma in
Africa. Estimating the magnitude of glaucoma in Nigeria
is important because it sheds light on inter-ethnic and
regional variations of OAG prevalence in the black
populations of Africa, Caribbean and USA. It will also
provide a baseline for planning delivery of care to glau-
coma patients in Nigeria and in countries with similar
socio-demographic and ecological characteristics in
sub-Saharan Africa.
Methods
Details of all the methods used in the Nigeria Blindness
Survey have been published [24] as well as data on the
prevalence [10] and causes of visual impairment, blind-
ness [11] and low vision [12].
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Ethics
Ethical approval was obtained from the Ethics Committee
of the London School of Hygiene & Tropical Medicine
and the Federal Ministry of Health, Nigeria. Oral informed
consent was obtained from community leaders, heads of
households and all participants. The study adhered to the
tenets of the declaration of Helsinki. Persons with medical
or eye conditions needing further assessment and treat-
ment were referred to the nearest healthcare facility. Cata-
ract blind participants were offered surgery after the
survey had been completed in each zone.
Sample size calculation and sampling strategy
The sample size calculation was based on the following:
target population (22.6 million); expected prevalence of
blindness in persons 40 years and older (5 %); desired
precision (0.5 %); design effect due to clustered sampling
(2); 95 % confidence level; and 85 % response rate. The
sample size was 15,375 after allowing for non-response
in 310 clusters of 50 participants each. With assumed
glaucoma prevalence of 5 % [3], this sample size would
also give a precise estimate of the prevalence of glau-
coma and allow risk factors for OAG to be analysed.
Multi-stage sampling using probability in proportion
to size was used to select a nationally representative
sample. In each cluster the center of the village/ward
was identified and the direction of enumeration deter-
mined by spinning a bottle. Individuals aged 40 years
and above who had lived in the household for at least
the preceding 3 months were enumerated until 50 indi-
viduals had been identified. Examination took place over
two days in a temporary clinic set up in the community.
Those unable to leave their homes (e.g., due to disability)
were examined at home.
Clinical teams and quality control
Data were collected by two clinical teams each comprising
of two ophthalmologists, one optometrist, two ophthalmic
nurses, four enumerators and one interviewer. Quality as-
surance included field supervision by the team leader, daily
review of data collection forms, frequent visits by the Pro-
ject Manager (MR) and Project Epidemiologist (GVSM),
inter-observer agreement studies, retraining of all team
members before visiting each zone, and double data entry
by two trained data entry personnel. Three of the four
ophthalmologists and both optometrists comprising the
clinical teams remained unchanged but different nurses
were recruited for each zone in order to address lan-
guage and cultural variations. A detailed protocol of all
the methods was used in training and for reference.
Data collection and clinical assessment
Clinical assessment in relation to glaucoma is described
below. The examination flow is shown in Fig. 1.
All participants
All participants had their personal and socio-demographic
data recorded including their self-reported ethnic group
as well as medical and ocular history, including a history
of glaucoma. Height, weight and blood pressure (Omron)
were measured. Presenting and best-corrected distant
visual acuities (VA) were measured by an ophthalmic
nurse with a reduced logMAR E-chart [25]. All partici-
pants also had automated refraction, frequency doubling
technology (FDT) visual field testing (see below), A-scan
biometry by the optometrist and a basic eye examination
by the first ophthalmologist.
Detailed examination
The following participants underwent detailed eye examin-
ation by the second ophthalmologist [10, 24]: those with a
presenting VA <6/12 in one or both eyes; VCDR ≥0.6 in
one or both eyes or VCDR asymmetry of ≥0.2, or any ret-
inal abnormality seen on non-dilated direct ophthalmos-
copy. In addition, 1-in-7 participants also had the detailed
examination regardless of their VA, with random blood glu-
cose testing, to provide a ‘normative’ database. Detailed eye
examination included slit-lamp examination (Zeiss SL 115
Classic Slit Lamp, Carl Zeiss Meditec AG Jena Germany),
Van Herick’s (VH) anterior chamber (AC) angle depth esti-
mation [26], assessment for relative afferent pupil defect
(RAPD), applanation tonometry (Goldmann), lens opacity
grading using the World Health Organization (WHO)
classification, fundus and optic disc examination with
60D aspheric condensing lens (Volk) and binocular in-
direct ophthalmoscopy (BIO; Keeler all-pupil) with a
20D lens, and digital fundus imaging with Zeiss Visucam
Lite Desk Top Fundus Camera (Carl Zeiss Meditec AG
Jena Germany) focused on mid-point between the optic
nerve head and the macular region through a dilated
pupil. All images were graded independently at the Moor-
fields Eye Hospital Reading Centre (MEHRC). Gonioscopy
(Volk’s 1-mirror non-flanged lens) was performed if the
IOP was ≥20 mmHg, or VCDR ≥0.6, or VCDR asymmetry
≥0.2, or VH grades 0, 1, 2. Central corneal thickness was
not assessed.
Visual field testing
Visual field testing was performed with a Humphrey
FDT visual field analyzer (Carl Zeiss Meditec AG Jena
Germany). The FDT perimeter is a robust, portable, self-
contained unit that weighs less than 10 kg and has a self-
calibration procedure. It is generally inexpensive, easy to
understand and quick to perform the test [27]: it takes
about 45 s to complete a normal screening test and about
45 s for a normal threshold test. These features informed
the choice of the FDT perimeter and were advantages
considering the logistics of a large population-based sur-
vey of this kind where examinations were carried out in
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temporary examination centers set up in the community.
FDT utilizes a vertical sine wave grating of low spatial fre-
quency (0.25 c/deg) with counterphase flickering at a high
temporal frequency (25 Hz) [28]. All participants were
screened using the suprathreshold (C20-5 or C20-1)
screening mode after explaining the test and running a
demonstration. Each eye was tested separately without
correction. The reliability indices considered were fixation
error and false positive. The screening test was stopped
and restarted or repeated if considered unreliable i.e.,
there were two or three false positives and/or two or more
fixation errors. Clinically abnormal tests were not re-
peated. A threshold test was done if there were ≥3 field
defects at p <1 % or ≥2 field defects at p <0.5 %. If a par-
ticipant could not be tested or could not see the FDT flick-
ering black and white patterns, s/he was classified as
having no FDT test and a reason was given e.g., cataract;
or did not understand the test. Print-outs of all FDT tests
were obtained immediately and data were extracted and
entered into a database. Perimetry results were interpreted
using a detailed specific algorithm (devised and adapted
[27] by PGS and FK) to identify abnormal visual fields and
to classify defects as glaucomatous or non-glaucomatous.
The criteria used are outlined in Table 1. The FDT result
was interpreted by a 1st reader (PM) and validated by a
2nd (FK); any discrepancy was adjudicated (PGS). Screen-
ing reliability was defined as ≤1 fixation error and/or ≤1
false positive (i.e., <33 % failed reliability indices) and
threshold reliability was defined as ≤2 fixation errors, ≤2
false positives (i.e., ≤33 % errors on reliability indices).
Tests were also considered unreliable if there were brow/
lid positions showing as uniformly dense artefact along
the upper or lower edges of the FDT result chart. Unreli-
able results were not included.
Threshold test results were used to diagnose glaucoma
if available, otherwise screening results were used. Grading
used defects on the Pattern Deviation Probability (PDP)
plot compared with the Total Deviation Probability (TDP)
plot. Screening tests were considered normal if reliable
without defects, or there were ≤2 defects at p <1 %; or ≤1
defect at p <0.5 %. Threshold tests were normal if there
were no defects at p <0.5 % and p <1 %, or ≤1 defect at p
<2 %, or ≤2 non-adjacent defects at p <0.5 %. Factors con-
sidered in categorizing defects as definitely, probably or
possibly glaucomatous were position, depth and size, clus-
tering (i.e., adjacent or not) and position; and repeatability
(i.e., defect in same location on PDP and TDP plots).
We could determine repeatability in participants that
had both screening and threshold tests. Defects were
not likely glaucomatous if 1) there was a highly shaded
Fig. 1 Examination flow chart for study participants in the Nigeria national survey of blindness and visual impairment. VA = visual acuity;
BNB = believed not blind; BB = believed blind, VCDR = vertical cup:disc ratio. Basic eye examination: (n=7194)- Pen-torch anterior segment
examination, non-dilated direct ophthalmoscopy. Detailed eye examination: (n=6397) - Slit-lamp examination, WHO lens grading, Van Herick's anterior
chamber angle depth estimation, applanation tonometry, gonioscopy if indicated, dilated ophthalmoscopy, digital retinal photography
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TDP with normal PDP plot – this diffuse loss could be
due to cataract, for example; 2) TDP was normal or
better than the PDP plot or 3) there were vertical me-
ridian defects. However, for diffuse defects, other com-
pelling evidence for glaucoma classification were used
(see later).
Van Herick’s anterior chamber angle estimation and
gonioscopy
The VH AC angle estimation was performed at the slit-
lamp. The relationship between the corneal slit image and
AC depth was graded 0 to 4 [26]. Grades 0, 1 and 2 were
grouped as angle closure or likely to close angles; and
grades 3 and 4 as open angles. The iridocorneal angle was
assessed by gonioscopy without corneal compression and
graded as either open angle or closed angle. The anterior
chamber angle was classified as open when Schwalbe’s
line could be seen; and as closed when it could not be
seen. In eyes with glaucoma, the correlation between
VH grades and gonioscopy was assessed with the kappa
statistic.
IOP measurement
Intraocular pressures were measured by Goldmann
applanation tonometry using standard methods and re-
corded to the nearest 1 mmHg. Tonometers were
checked for calibration daily according to the manufac-
turer’s recommendation. Eyes with significant corneal
surface pathology, phthisis or participants unable to fix-
ate were excluded.
Optic disc assessment
Cup-disc ratios were assessed clinically by direct oph-
thalmoscopy for all participants during the basic exam-
ination, and after pupil dilation in those having the
detailed examination using slit lamp biomicroscopy with
a 60D lens. Clinical grading was used in analysis for
participants that did not have photo VCDR grading.
Methods for clinical VCDR grading by the ophthalmolo-
gists were standardized during training using standard sets
of optic disc photographs and comparing the clinical grad-
ing with the VCDR measured on the retinal photo of the
participant being observed.
Digital fundus images were graded independently by
MEHRC using their standard protocol. Images were viewed
"full screen" on either a 24-in. Eizo S2433W monitor or on
a 24-in. widescreen Dell 2407WFP LCD monitor. The
former was calibrated using a Datacolor Spyder2 calibrator
and the latter was calibrated using a GretagMacbeth Eye-
One Display2 calibrator. After determining image quality
and clarity, the scleral rim was identified and the boundar-
ies of the disc and cup identified using monocular clues
such as vascular change in direction. Disc pallor gave few
clues and was not used. The VCDR was then quantified.
One successful measurement was performed per eye, along
the vertical meridian, in Adobe Photoshop (version 7) using
the measurement tool, resulting in a cup and a disc diam-
eter value in proprietary units, the division of the two
values producing the VCDR which was recorded to the
nearest 0.05. Primary grading was performed by the 1st
reader (FS) and inconclusive cases, e.g., tilted discs, blurred
images, generalized disc pallor, were adjudicated by a 2nd
reader (TP) immediately. If a VCDR measurement could
not be obtained, this was stated.
Inter-observer agreement for clinical VCDR measure-
ment between ophthalmologists was assessed with the
kappa statistic; each participant had two observations with
the second examiner blinded to the result obtained by the
first examiner. Inter-observer agreement for VCDR grad-
ing on photos was also assessed. The Bland-Altman
method was applied to assess agreement between the
two methods of measurement i.e., by biomicroscope
funduscopy (clinical VCDR) and digital image analysis
(image VCDR).
Table 1 Definition of glaucomatous visual field defects for level 1 evidence of glaucoma
FDT test defects Visual fields
Normal Definitely glaucoma Probably glaucoma Possibly glaucoma Unlikely glaucomaa
P <5 % 2 or less non-adjacent 4 3 2 adjacent
P <2 % 1 3 2 1
P <1 % 0 2 1 non-edge
P <0.5 % 0 1 1 non-edge
Comments At any location in any
hemi-field
At one hemi-field At one hemi-field If TDP plot is better than
PDP plot
Participants with glaucoma Total
Number of participantsb 268 (100 %) 252 (94 %) 6 (2.2 %) 9 (3.4 %) 1 (0.4 %)
Number of eyes 310 (100 %) 283 (91.3 %) 9 (2.9 %) 13 (4.2 %) 5 (1.6 %)
TDP total deviation probability, PDP pattern deviation probability
aOther evidence of glaucoma noted in those classified as glaucoma
bIn participants with bilateral glaucoma, the eye with the highest level of evidence is used to classify that person
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Glaucoma diagnostic algorithm
Glaucoma was classified according to the ISGEO criteria,
using percentile distributions of VCDR, VCDR asymmetry
and IOP in normal Nigerians, derived from the normative
dataset (n = 1759) of this study population [29] (Table 2).
The diagnosis of glaucoma started with VCDR findings
(Fig. 2). Category 1 required structural and functional evi-
dence i.e., 97.5th percentile of the VCDR (≥0.7) or VCDR
asymmetry (≥0.1) in our normal population and visual
field loss typical of glaucoma. Category 2 required ad-
vanced structural damage i.e., 99.5th percentile VCDR
(≥0.75) or VCDR asymmetry (≥0.2) in the absence of
Table 2 International Society of Geographical and Epidemiological Ophthalmology (ISGEO) definitions for glaucoma used in analysis
(Adapted From Foster, 2002) [13]
VCDR or VCDR asymmetry
Level of evidence Image reading
analysis
Clinical records
analysis
Visual fields Intraocular pressure Visual
acuity
Medical history
Other features
Category 1 ≥97.5th percentile: ≥97.5th percentile: Typical defect
VCDR 0.7 0.6
VCDR asymmetry 0.1 0.2
Category 2 ≥99.5th percentile: ≥99.5th percentile: Not available
VCDR 0.75 0.7
VCDR asymmetry 0.2 0.3
Category 2b ≤97.5th percentile: 0.7 ≤97.5th percentile: 0.6 ±Typical defect ≥99.5th percentile: 28 mmHg RAPD, Corneal edema
Category 3 Not available Not available ≥99.5th percentile: 28 mmHg <20/400 Surgery for glaucoma
VCDR vertical cup:disc ratio, RAPD relative afferent pupillary defect
Fig. 2 Glaucoma diagnostic algorithm and number of glaucoma participants in each category
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visual field evidence i.e., when a useful visual field result
was not possible or available. Category 3 applied when the
optic disc was not seen and visual field testing was not
possible, and used: a) blindness (VA <3/60) with the 99.5th
percentile IOP (≥28 mmHg), or b) diagnosed with/being
treated for glaucoma. An additional level of evidence (level
2b) was added where the optic disc was visualized but the
VCDR was <99.5th percentile and visual fields were not
available or if visual fields were interpreted as “unlikely
glaucoma” but there were other compelling evidence such
as RAPD, high IOP and/or corneal edema. Other glau-
comatous optic nerve head features such as localized nar-
rowing of the rim, optic disc hemorrhages, and retinal
nerve fiber layer defects are not included in the ISGEO
classification, and so individuals with these signs only (i.e.,
no visual field defects; IOP within the normal range for
the study population) would not have been classified as
having glaucoma. These cases were adjudicated by glau-
coma specialists (RW and WN). A person was said to have
glaucoma if there was glaucoma in one or both eyes.
Type of glaucoma
Glaucoma was classified as primary and secondary
glaucoma. Primary glaucoma was classified as primary
open-angle glaucoma (POAG) or primary angle-closure
glaucoma (PACG) according to angle morphology viewed
by gonioscopy. Glaucoma was classified as secondary where
there was an underlying cause such as AC angle neovascu-
larization, exfoliation, pigment dispersion, trauma, surgical
procedure, couching or uveitis. The type was unclassified in
eyes that did not have gonioscopy.
Data analysis and statistical methods
Visual acuities were categorized using the WHO classifi-
cation of blindness and visual impairment with addition
of a category for mild visual impairment (worse than 6/
12 but up to 6/18). The classification uses presenting VA
in the better seeing eye. Age was categorized in 10-year
groups. Any ability to read and write was classified as
literate. Ethnic groups represented by ≥200 participants
were analyzed separately (i.e., Hausa, Yoruba, Igbo, Fu-
lani, Kanuri, Nupe, Ijaw, Ibibio, Tiv and Urhobo). Ethnic
groups with <200 participants were grouped as “Others”
and analyzed collectively. Settlements with a population
of ≤20,000 were classified as rural.
The percentile VCDR values used for classification of
glaucoma in this study were derived from the photo
VCDR grades of the ‘normative’ data. The percentile
values for the distribution of the clinical VCDR records
are included in Table 2 for comparison.
Statistical analysis was performed using Stata (Stata/IC
13.0; Stata Corp, College Station, TX). A descriptive analysis
of the study population was undertaken. Univariate analysis
was performed to describe socio-demographic characteris-
tics (age, gender, ethnic group, literacy and rural/urban
place of residence). The age/sex-specific prevalence of glau-
coma with 95 % confidence intervals (CI) was calculated
taking account of additional variation introduced by the
stratified cluster sampling design. Missing values were indi-
cated and excluded in the analysis.
Results
A total of 15,027 adults aged ≥40 years were enumerated
in 310 clusters, 13,591 (90 %) of whom were examined in
305 clusters. 6,397 participants had detailed eye examin-
ation, 3814 (59.6 %) of whom had images for VCDR as-
sessment in both eyes and 817 (12.8 %) in one eye. Where
there was no disc image (2624 eyes of 1329 [20.8 %]
participants), clinical VCDR grade was used (Table 3).
Reasons why there were no disc images are stated in
Table 4. Photos were ungradable if no optic disc features
could be assessed due to blur or wrong field definition.
Clinical VCDR grades were also used in participants
undergoing the basic eye examination only. In the whole
study sample, a total of 25,289 (93 %) eyes of 13,081 (96 %)
participants had photographic or clinical VCDR grades;
510 (4 %) participants did not have VCDR graded in both
eyes (Fig. 2).
Table 3 Summary of completeness of data for participants undergoing full examination (N = 6397)
Eye level data Person level data
Right eye Left eye All eyes One/both eyes Both eyes
N % N % N % N % N %
Total 6397 6397 12,794 6397 6397
Examination
Van Herick’s 5830 91.1 5821 91.0 11,651 91.1 5967 93.3 5684 88.9
Intra-ocular pressure 5496 85.9 5478 85.6 10,974 85.8 5638 88.1 5336 83.4
Disc grading
Photo 4203 65.7 4242 66.3 8445 66.0 4631 72.4 3814 59.6
Clinical 1320 20.6 1304 20.4 2624 20.5 1329 20.8 993 15.5
None 874 13.7 851 13.3 1725 13.5 – – 437 6.8
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The kappa for inter-observer agreement on ophthal-
mologists’ clinical measurement of VCDR within 0.1 was
κ = 0.86 (almost perfect agreement) and classifying ≥0.6
or <0.6 was κ = 0.47 (moderate agreement). Overall, the
inter-observer agreement between graders for the image
VCDR grading at MEHRC was 99.7 %. The Bland-Altman
limits of agreement between the clinical and the image
VCDR measurements for 95 % of eyes were lower limit of
−0.2 to upper limit of 0.3; and 93 % eyes had a difference
of ≤0.25 between the two methods of VCDR measure-
ment. In participants undergoing detailed eye examination
(n = 6397), 93 % and 88 % had VH AC depth estimation
and IOP measurement in at least one eye, respectively
(Table 3). With 94 % agreement, the kappa for correlation
of gonioscopy (closed/open) Vs VH AC (grades 0–2/3–4)
in 397 eyes with glaucoma was κ = 0.70 (substantial
agreement).
As shown in Fig. 2, 770 participants had VCDR ≥ 0.7 in
one or both eyes and a further 3768 had VCDR asym-
metry ≥ 0.1, thus a total of 4995 eyes in 4538 participants
required visual field analysis (for level 1 evidence) which
were available for 3016 (60.4 %) eyes of 2725 (60.1 %) per-
sons. Glaucoma was diagnosed in 63 % (485/770) par-
ticipants with VCDR ≥0.7/0.75, and in 4.1 % (156/3768)
participants with VCDR asymmetry. Other participants
were assessed for level 2b and level 3 evidence. The
diagnosis of glaucoma was made in a total of 950 eyes
of 682 participants - by photo VCDR in 352 (51.6 %),
clinical VCDR in 294 (43.1 %) and the disc was not
seen in 36 (5.3 %). Thus, glaucoma diagnosis was made
by level 1 evidence in 268 (39.3 %), level 2 evidence in
373 (54.7 %), level 2b in 5 (0.7 %) and level 3 in 36
(5.3 %) participants (Table 5).
Prevalence and types of glaucoma
The prevalence of glaucoma of all types was 5.02 % (95 %
CI 4.60–5.47 %). The prevalence increased with increasing
age and was higher in males, those who were not literate
and the Igbo ethnic group (Table 6). These differences
were statistically significant. The age-specific prevalence
and the magnitude of glaucoma in Nigeria derived by dir-
ect standardization with the 2012 Nigeria population are
shown in Table 7. There are estimated to be 1.2 million
Nigerians aged ≥40 years with glaucoma.
Among the 243 participants with primary glaucoma
classified according to pathophysiology based on AC
angle morphology by gonioscopy, 208 (86 %) were classi-
fied as POAG and 35 (14 %) as PACG (Table 8). PACG
was more common in women but the difference was not
statistically significant (p = 0.08). There were no differ-
ences in age, ethnic distribution or rural/urban place of
residence between the two groups. Additionally, there
was no statistically significant difference in awareness of
having glaucoma (p = 0.55): 1 in 8 of those with POAG
and 1 in 12 of those with PACG knew they had the dis-
ease. IOPs were higher in PACG than POAG: the mean
IOP was 34 mmHg, standard deviation (SD) 13 in PACG
and 27 mmHg, SD 11 in POAG (p <0.001).
Table 4 Reasons why there was no photo disc grading in
4349 (34 %) eyes among those who had full examination
(n = 12,794 eyes)
Reason Right eye Left eye All eyes %
Eye disease
Cataract 552 469 1021 24 %
Corneal opacity 304 295 599 14 %
Other ocular pathology 166 192 358 8 %
1978 46 %
Participants factors
Uncooperative 27 31 58 1 %
Other e.g., home visit 31 27 58 1 %
116 2 %
Technical reasons
Faulty camera 471 472 943 22 %
No electricity 144 144 288 7 %
1231 28 %
Other
No reason stated 271 312 583 14 %
Ungradable photosa 228 213 441 10 %
1024 24 %
Total 2194 2155 4349 100 %
aPhotos were taken but VCDR could not be assessed because of blurred image
due to media opacity or poor positioning of the participant
Table 5 Classification of participants with glaucoma by levels of
evidence (as described in Table 2)
Participants with glaucoma
Level of evidence Number of participants Number of eyes
Category 1
VCDR 155 (22.7 %) 197 (20.8 %)
VCDR asymmetry 113 (16.6 %) 113 (11.9 %)
Total 268 (39.3 %) 310 (32.7 %)
Category 2
VCDR 330 (48.4 %) 511 (53.8 %)
VCDR asymmetry 43 (6.3 %) 43 (4.5 %)
Total 373 (54.7 %) 554 (58.3 %)
Category 2b 5 (0.7 %) 10 (1.0 %)
Category 3 36 (5.3 %) 76 (8.0 %)
Total glaucoma 682 (100 %) 950 (100.0 %)
VCDR vertical cup:disc ratio
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Other findings
Only 5.6 % (38/682) of all participants with glaucoma
knew they had the condition. The commonest causes of
secondary glaucoma (n = 53 participants) were couching
(an ancient, traditional non-medical manipulation of the
crystalline lens; 38 %), trauma (21 %), uveitis (19 %) and
following intracapsular cataract surgery (17 %). Over a
third of the eyes with glaucoma (365; 38 %) had a present-
ing VA worse than 3/60; and 1 in every 5 persons with
glaucoma (136; 20 %) was blind (VA worse than 3/60 in
the better eye). In 68 % of the 136 blind with glaucoma,
the main cause of blindness was attributable to glaucoma.
Among the 40–49 year-group with glaucoma, 13 % were
blind, and this age-specific proportion of blindness among
glaucoma participants increased with age to 30 % in the
80+ years age-group.
Figure 3 shows the distribution of IOP in all eyes: the
mean IOP was 14 mmHg, SD 4 in the non-glaucomatous
eyes compared to 23 mmHg, SD 12 in the glaucoma eyes.
The difference in the mean values was statistically signifi-
cant (p <0.001). The modal IOP was 12 mmHg in both
groups. There were three different peaks at 12, 28 and
Table 6 Socio-demographic characteristics of participants with glaucoma in the study population
Total Participants with glaucoma
N N % 95 % CI
Total 13,591 (100 %) 682 5.02 4.60–5.47
Socio-demographic factors
Age group (years) 40–49 4889 93 1.90 1.55–2.33
50–59 3577 130 3.63 3.03–4.36
60–69 2773 178 6.42 5.50–7.48
70–79 1653 178 10.77 9.24–12.52
80+ 699 103 14.74 12.31–17.54
p <0.001
Gender Female 7345 328 4.47 3.98–5.00
Male 6246 354 5.67 5.05–5.47
p = 0.002
Ethnic groupa Hausa 3375 130 3.85 3.00–4.93
Yoruba 2669 156 5.84 4.94–6.90
Igbo 1918 149 7.77 6.57–9.16
Fulani 840 30 3.57 2.53–5.01
Kanuri 353 18 5.10 3.40–7.58
Tiv 342 11 3.22 2.29–4.51
Ijaw 251 15 5.98 4.46–7.96
Urhobo 245 7 2.86 1.50–5.37
Ibibio 212 12 5.66 2.35–13.03
Nupe 211 11 5.21 3.41–7.88
Others 3117 139 4.46 3.72–5.33
p <0.001
Literacy Literate 5925 248 4.19 3.60–4.86
Illiterate 7666 434 5.66 5.14-6.23
p = 0.001
Place of residence Rural 10,540 520 4.93 4.46–5.46
Urban 3051 162 5.31 4.47–6.30
p = 0.473
Visual status Not blind 13,022 546 4.19 3.83–4.59
Blind 569 136 23.90 20.24–27.99
p <0.001
CI = confidence interval
a58 missing values excluded
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50 mmHg in the IOP distribution of the eyes with glau-
coma. About half (56 %) of the eyes with glaucoma had
IOP ≤22 mmHg. Conversely, 4 % had IOP >21 mmHg but
did not have glaucoma.
Discussion
The Nigeria Blindness Survey was the largest, national
population-based survey of eye disease in an ethnically di-
verse, indigenous black African population, giving precise
estimates of the prevalence of glaucoma. The sample was
nationally representative by age, gender, ethnicity, rural/
urban residence and socioeconomic status [24], with a
high response rate and the results are generalizable to the
whole country and also to people of the West African
diaspora around the world whose predecessors were vic-
tims of the slave trade e.g., African Caribbean and African
American people. Though now genetically mixed to vary-
ing extent, our study population is likely to have the same
genetic determinants of the glaucoma seen in those popu-
lations. Additional strengths are the standardized protocol,
the same clinicians and equipment were used throughout
the study, and photographic VCDR grading was performed
by the MEHRC, an independent, internationally recognized
reading center. Furthermore, the centile values for VCDR
and IOP distribution in the population used to define glau-
coma were derived from the same study population.
The survey indicates that 1.1 to 1.4 million adults in
Nigeria have glaucoma, most of whom are not aware that
they have the disease. One in every 20 Nigerians aged
40 years and above has glaucoma, and one in five being
blind. There are approximately 8500 people aged 40 years
and above with glaucoma per million population. The
high prevalence and high rate of blindness confirm glau-
coma to be of public health importance and should be-
come a priority among healthcare planners and policy
makers, emphasizing the need for glaucoma care pathways
for early detection and treatment to prevent blindness. In
Nigeria, 8 % of glaucoma was secondary, with over half
of these following procedures for cataract, particularly
couching, which is still widely practiced in Nigeria despite
very poor visual outcomes [30]. This underscores the need
for high quality, affordable and accessible cataract surgical
services. The findings have public health implications for
other countries in sub-Saharan Africa which share similar
socio-demographic characteristics.
The prevalence of glaucoma in Nigeria is similar to that
in Temba, South Africa [20], slightly higher than in South
African Zulus [19] and in Kongwa, Tanzania [18] but lower
than in Tema, Ghana [21] and Akinyele, SW Nigeria [22].
Although these surveys were undertaken in localized pop-
ulations, there seems to be an emerging pattern with the
prevalence being higher in West Africa than in South
Africa which in turn is higher than in East Africa. The
Ghana study [21] had a high proportion of Level 1 diagno-
sis (87.2 %) compared with our study (39.3 %) as in Nigeria
there were high rates of cataract and other pathology
which precluded visual field assessment. As Level 2 re-
quires evidence of more advanced structural damage our
estimates for Nigeria are, therefore, minimum estimates.
The prevalence of glaucoma in Nigeria is lower than that
of POAG reported from Barbados (6.7 %, 95 % CI 6.3–7.8)
[17], being similar to black populations in the United
States of America (USA) [15] but slightly higher than in
Asian populations [31–38] and much higher than white
populations in the USA [15, 39], Australia [40] and Europe
Table 7 Age-standardized glaucoma prevalence rates
Study sample Prevalence of glaucoma Magnitude of glaucoma
Crude rate Age-adjusted ratea Estimated numbers
N % N % % 95 % CI
Age group (years)
40–49 4889 35.97 93 1.90 1.51 1.96–2.94 166,308
50–59 3577 26.32 130 3.63 3.69 2.98–4.29 232,792
60–69 2773 20.40 178 6.42 8.85 3.99–5.43 318,689
70–79 1653 12.16 178 10.77 16.85 5.91–8.00 321,820
80+ 699 5.14 103 14.74 12.32 14.72–20.98 181,807
Total 13,591 100 682 5.02 5.02 4.60–5.47 1,221,416
CI confidence interval
aStandardized with the 2012 Nigeria population
Table 8 Proportion of the different types of glaucoma in the
Nigeria National Survey of Blindness and Visual Impairment
Proportion of glaucoma
Glaucoma type N %
All glaucomaa 682 100.0
POAG 208 30.5
PACG 35 5.1
Secondary glaucoma 53 7.8
Unclassifiedb 386 56.6
POAG primary open angle glaucoma, PACG primary angle-closure glaucoma
aAll glaucoma prevalence is 5.02 % (95 % CI 4.60–5.47 %)
bNo data on gonioscopy, thus not classified by anterior chamber angle morphology
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[41–44]. The prevalence of glaucoma in Nigeria is also
higher than in Brazil [45], Iran [46], indigenous popula-
tions in Australia [47] and Qatar [48]. Regional/racial vari-
ations in prevalence have been attributed to genetic and
possible environmental differences [49, 50]. Susceptibility
gene loci significantly associated with POAG and genes
involved in IOP regulation have been studied in some
African populations [51, 52]. In Nigeria, the Igbo, a rather
homogenous ethnic group, had the highest prevalence of
glaucoma which may also reflect genetic susceptibility.
The relatively high age-specific prevalence of glau-
coma in 40–49 year olds in Nigeria and the high pro-
portion of glaucoma blindness suggest severity at an
earlier age [15, 17, 21, 22] and more aggressive course [53]
in Blacks than in Caucasians [41, 42, 44] and some Asian
populations [33, 34] over and above lack of diagnosis and
treatment since the high proportions of undiagnosed glau-
coma are relatively similar (Table 9). However, this could
also be the natural history signifying poor access to treat-
ment. Additionally, because of the earlier age of onset and
longer years with untreated glaucoma, the risk of going
blind would be much greater. The racial/regional dispar-
ity in disease severity may be attributed to additional
factors such as inflammation [54, 55] and the different
peaks of IOP in eyes with glaucoma may indicate gen-
etic susceptibility at varying levels of IOP. However,
these interpretations are speculative and warrant fur-
ther research.
The classification of glaucoma by pathophysiological
mechanism based on angle morphology is important be-
cause POAG and PACG have different natural histories
and different management strategies. In Nigeria POAG
was the commonest type of glaucoma, as reported in
other black populations [3, 15–22, 45].
It is acknowledged that communities in Nigeria, where
prior diagnosis of glaucoma is low, have extremely little
knowledge about glaucoma. Questions were, therefore,
not asked on whether first-degree relatives had glaucoma
as participants would be highly unlikely to know. In
addition, the ISGEO classification does not take first-
degree relatives into account.
It is noteworthy that at least half of the glaucoma eyes
had an IOP less than the mean +2SD IOP (22 mmHg) of
non-glaucoma participants. The important implication is
that IOP is unable to differentiate between those with
glaucoma and those without glaucoma.
A limitation of this study is that the ‘gold standard’
Humphrey field analyzer was not used as, unlike the port-
able FDT perimeter, it would not have been feasible to
transport it to all examination centers especially in the ter-
rain and environment of the survey. Nevertheless, we had
an acceptable and reproducible test of visual function
based on the central 20° field of vision. Another limitation
was that pachymetry was not done. The data would have
added more information on corneal thickness in relation
to glaucoma. Interestingly, in the Barbados Eye Studies,
corneal thickness tended to be thinner in the black partici-
pants than in the white participants but was not correlated
to IOP [56]. However, as corneal thickness decreased,
there was a higher likelihood of incident OAG [57]. Also,
not all participants had dilated disc assessment or photo-
graphic disc grading as this was not possible given the
large sample size of the study. The fundus camera pro-
duced non-stereoscopic images and monocular clues were
used to determine optic disc and cup boundaries. Though
this may have led to misclassification, most of the cases
classified as glaucoma in this survey were “barn-door”.
Even though there is a tendency for non-stereoscopic
Fig. 3 Distribution of IOP in glaucoma and non-glaucomatous eyes
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assessments to yield slightly varied optic disc parameters
[58, 59], these differences were inconsistent and the agree-
ment between stereoscopic and non-stereoscopic VCDR
assessment were generally extremely good and repeatable
[58]. A further limitation was that the fundus camera was
not calibrated for disc size so VCDRs could not be ad-
justed for disc size. Technical difficulties in the field (faulty
camera or generator) meant that disc images were not ob-
tained in 616 participants when needed. High humidity
damaged the mirror coating of gonioscopy lenses so that
some eligible participants did not have gonioscopy per-
formed and VH AC angle estimation was used instead.
Hence, the proportions for angle-closure glaucoma and
open-angle glaucoma were obtained only from partici-
pants that had gonioscopy. Additionally, lack of indenta-
tion gonioscopy, use of a one-mirror gonioscopy lens, and
defining open-angle glaucoma as a visible Schwalbe’s line
may have led to some misclassification of the type of glau-
coma. The survey protocol indicated detailed eye exam-
ination of those with VCDR asymmetry of ≥0.2 whereas
the asymmetry required for Level 1 diagnosis in later
analysis was found to be 0.1. In individuals with VCDR
asymmetry between 0.1 and 0.2, the diagnosis of glau-
coma was based on the presence of glaucomatous visual
fields. The ISGEO classification system is designed to
identify moderate, severe glaucoma and those blind
from glaucoma and therefore glaucoma ‘suspects’ and
those with early disease may not have been captured.
Our estimate is, therefore, a minimal estimate.
One survey team inadvertently used the C-20-1 FDT
screening mode in 141 clusters. The C-20-1 mode has
greater specificity and is less likely to misclassify a normal
field. The C-20-5 has higher sensitivity at detecting early
defects at the expense of lower specificity. To overcome
Table 9 Prevalence of Glaucoma in some population-based studies for age ≥40 years
Study population Examined
(response rate %)
Prevalence of glaucoma Undiagnosed
glaucoma (%)
Proportion
blind (%)
Reference
n All glaucoma %
(95 % CI)
40–49 years age-specific
Nigeria, National 13,951 (90) 682 5.0 (4.6–5.5) 1.9 (1.6–2.3) 94 20 This study
Africa
Kongwa, Tanzania 3247 (89) 135 4.2 (3.5–4.9) 1.7 (1.1–2.5) 98 14 [18]
Hlabisa, South Africa 1005 (90) 41 4.5 (3.2–6.1) 1.2 (0.2–3.4) 90 [19]
Temba, South Africa 839 (75) 55 5.3 (3.9–7.1) 1.1b 87 [20]
Tema, Ghana 5603 (82) 32 6.5 (5.8–7.1) 3.2 (2.7–4.1) 97 3 [21]
Akinyele, Nigeria 811 (90) 59 7.3 (5.5–9.1) 4.6 (2.1–7.1) 90 6 [22]
Asia
Qatar 3149 (97) 67 1.7 (1.7–1.8) 1.45 b 51 6 [48]
Yazd, Iran 1990 (86) 87 4.4 (3.3–5.4) 1.6 (0.8–2.4) 90 [46]
Chinese, Singapore 1232 (72) 45 3.2 (2.3–4.1)a 1.1 (0.2–4.8) 62 [31]
Chinese, Singapore 3353 (73) 134 3.2 (2.7–3.9)a 0.7 b 85 10 [38]
Malay, Singapore 3280 (79) 150 3.4 (3.3–3.5)a 2.2 b 92 10 [36]
Indian, Singapore 3400 (76) 78 1.9 (1.5–2.5)a 1.3 b 72 10 [35]
Beijing, China 4439 (83) 158 3.7 (3.1–4.2) 2.2 (1.5–3.0) - 2 [37]
Kailu, China 5197 (87) 169 2.9 (2.0–3.8)a 2.0 (1.3–2.7) 66 7 [32]
Bhaktapur, Nepal 3991 (83) 75 1.8 (1.7–1.9)a 0.3 b 96 2 [33]
Central India 4711 (80) 122 3.5 (2.8–4.1) 1.0 (0.5–1.6) – 1 [34]
Australia
Indigenous, Australia 1061 (64) 26 2.2 (1.6–3.6) 1.5 (0.4–2.5) 81 12 [47]
Europe
Ponza, Italy 1034 (84) 39 3.8b 0 (0.0–1.7) – [42]
Egna-Neumarkt, Italy 4297 (74) 121 2.9b approx 0.5 b – [41]
Wroclaw, Poland 4853 (83) 79 1.6 (1.3–2.0) 0.4 (0.1–1.1) 71 [44]
CI confidence interval
aAdjusted rates
b95 % confidence interval not reported
– no data
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the difference visual fields were classified according to the
probability of pattern deviation and were equalized for the
2 screening modes.
Having described the high prevalence and distribution
of glaucoma in this comprehensive and representative
study, we are obliged to recommend a strategy for the
prevention blindness and visual impairment from glau-
coma in Nigeria and more widely in West Africa. The
clinical care of glaucoma in Nigeria remains challenging
and we suggest a top-down approach [60].
Conclusion
This nationally representative survey in Nigeria indicates
a high prevalence of glaucoma, with ethnic variation, se-
verity at an earlier age and high rates of blindness. The
latter is likely to reflect an aggressive natural history as
well as lack of awareness of the condition and low levels
of treatment. Most glaucoma in Nigeria is POAG with a
high proportion of secondary glaucoma being the conse-
quence of procedures for cataract. The findings shed
light on the more severe and prevalent disease seen in
black communities of the West African diaspora around
the world and quantify the enormous challenge of pre-
venting blindness from glaucoma in West Africa and in
people of this ethnic origin. Public health control strat-
egies with high quality integrated glaucoma care services
will be required to reduce morbidity and blindness.
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